Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-23T13:53:08.905Z Has data issue: false hasContentIssue false
  • English
  • Français

Assaying Depleted Uranium in Bones In-Situ Using A Non-Invasive X-Ray Fluorescence Technique

Published online by Cambridge University Press:  06 March 2019

P. Bloch  and
I.M. Shapiro
P. Bloch
Affiliation:
Univ. of Penn. Institute of Environmental Studies School of Medicine, Dept. of Radiation Oncology
I.M. Shapiro
Affiliation:
Univ. of Penn. Institute of Environmental Studies School of Dental Medicine, Dept. of Biochemistry, Philadelphia, Pa, 19104
Get access

Abstract

The occupational exposure to uranium associated with milling and fabrication of depleted uranium is presently assessed from bioassay of urine samples. The evaluation of the body-burden of uraninm from urine analysis has many difficulties and uncertainties associated with accounting for the bio-transport of inhaled uranium psrticles from the lungs, to absorption in the blood and excretion through the kidneys. The chemical toxicity of uranium and other transuranic elements is not fully understood, partially because of the difficulty of assessing the body burden of these metals in-situ. The transuranic elements are known to be deposited and retained in bone. A non-invasive X-ray fluorescence technique has been developed to assay the depleted uranium in bones in-situ. The K-shell electrons in uranium, which have a binding energy of 115.6 key are excited by the 122 and 136 keV gamma rays from a Co-57 source. A liquid N2 cooled intrinsic Ge-detector is employed to measure the characteristic K fluorescence from the uranium as well as the coherently scattered gamma raj's from the Co-57 source. The quantity of uranium in the bone is determined from the number of K fluorescence events extracted from the measured scattered photon spectrum. In addition, the bone mineral mass is determined from the number of coherently scattered gamma rays, permitting the assay of uranium to be expressed in terms of micrograms per unit mass bone. Using this system it was possible to measure molar concentrations of uranium with high precision and reproducibility.

Type
VIII. In Vivo Applications of XRS
Information
Advances in X-Ray Analysis , Volume 38: Forty-third Annual Conference on Applications of X-ray Analysis , 1994 , pp. 595 - 599
Copyright
Copyright © International Centre for Diffraction Data 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agarwal, M., Bennett, R. B., Stump, I.G. & D'Auria, J.M. (1975). Analytical Chemistry 47, 924.Google Scholar
Allard, D. J., Vumbaco, F. J., Schlier, D.S., Fogarty, K.P. & O'Keefe, F G. (1984). Presentation. Health Physics Society Meeting, New Orleans.Google Scholar
Bloch, P, Garavaglia, G, Mitchell, G, et al (1976). Phys, Med. Biol, 20, 56–63.Google Scholar
Eidson, A.F. & Mewhinney, J.A. (1980) Health Physics 39, 893–902.Google Scholar
Hu, R, Milder, F. L., Burger, D.E. (1989). Environ. Res. 49 295–317.Google Scholar
Kathren, R.L., Mclnroy, J. E, Moore, R.h., & Dietert, S.E. (1989)., Health Physics, 57, 17–21.Google Scholar
Kocher, D.C. (1989) Health Physics, 57, 9–15.Google Scholar
Kosnett, MJ, Becker, CE, Osterlok, JD, & Kelly, TJ. (1994). JAMA, 271:3, 197–203.Google Scholar
Lapham, S. C, Millard, J.B. & Samet, J.M. (1989). Health Physics 56, 327–340.Google Scholar
Singh, N. E, Lewis, L.L. & Wrenn, M.E. (1989). Health Physics 56, 341–343.Google Scholar
Sulu Zhao, F. Y. (1990). Health Physics, 58, 619–623.Google Scholar